Woodline Partners LP

Position in ABSI — Absci Corp

CIK 1784547 San Francisco, CA

Position in ABSI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$31,300,823

+$21,400,316 QoQ

Shares Held

2,700,675

-18.2% QoQ

Ownership

1.57%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#13

of 195 holders

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. ABSI ranks #42 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,002,863	$375,096,182
2	PTGX	Protagonist Therapeutics, Inc	1,414,173	$173,349,326
3	TNGX	Tango Therapeutics, Inc.	4,000,567	$125,057,724
4	BHVN	Biohaven Ltd.	7,660,280	$113,984,966
5	COGT	Cogent Biosciences, Inc.	2,603,162	$100,742,369
6	CYTK	Cytokinetics Inc	1,100,708	$93,769,314
7	RCUS	Arcus Biosciences, Inc.	3,007,798	$92,730,412
8	ROIV	Roivant Sciences Ltd.	2,500,673	$88,498,817

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$31,300,823	2,700,675	-18.2%	Shares	Sole	2026-08-14
2026-03-31	$9,900,507	3,300,169	+44.7%	Shares	Sole	2026-05-15
2025-12-31	$7,959,932	2,280,783	+28.9%	Shares	Sole	2026-02-17
2025-09-30	$5,380,942	1,770,047	-40.3%	Shares	Sole	2025-11-14
2025-06-30	$7,622,892	2,966,106	+113.2%	Shares	Sole	2025-08-14
2025-03-31	$3,492,024	1,391,245	+32.9%	Shares	Sole	2025-05-15
2024-12-31	$2,743,074	1,046,975	-49.9%	Shares	Sole	2025-02-14
2024-09-30	$7,986,859	2,090,801	+41.7%	Shares	Sole	2024-11-14
2024-06-30	$4,543,234	1,475,076	+0.1%	Shares	Sole	2024-08-14
2024-03-31	$8,373,370	1,474,185	+742.4%	Shares	Sole	2024-05-15
2021-09-30	$2,035,250	175,000	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.